The approval was based on data from the randomized, double-blind, placebo-controlled phase 3 SELECT-GCA trial.

Pacira BioSciences has announced that its gene therapy candidate, PCRX-201 (enekinragene inzadenovec), has demonstrated ...

Bob Baffert looks a little thinner to me, but maybe that’s because we haven’t seen him in awhile. Not in person, anyway. There are a few more ...

Disgraced and decorated, Bob Baffert is back at Churchill Downs this week ahead of the 151st Kentucky Derby with a tale to ...

Seasonal allergies also increase the risk of developing sinus and ear infections and increase the risk of asthma. Strategies to manage symptoms include medications, limiting exposure to pollen and ...

The Horseracing Integrity and Welfare Unit has sanctioned Tampa Bay Downs-based trainer Scooter Davis after one of his horses tested positive for the corticosteroid dexamethasone after a March 15 race ...

Results presented here showed intra-articular injections of platelet-rich plasma may be inferior to corticosteroid injections ...

Results of the study showed that 51.1% of benralizumab-treated patients compared with 45.4% of mepolizumab-treated patients attained a complete or partial response at 3 months. Notably, the complete ...

Folks with asthma might better control their symptoms by precisely timing when they use their inhaler, a new study says. A ...

Researchers have developed and preliminarily tested a composite score that simultaneously assesses the severity of asthma and chronic rhinosinusitis with nasal polyps (CRSwNP) in patients with both ...

A single daily preventer dose of inhaled corticosteroid (beclomethasone), taken mid afternoon, may be the best timing for effective asthma control as it suppresses the usual nocturnal worsening of ...